PDL BioPharma, Inc. · Incline Village, NV United States (NASDAQ: PDLI)
Key PDL BioPharma, Inc. Financials
| Company Type | Public -(NASDAQ: PDLI) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $345.0 |
| 2010 Employees | 9 |
PDL BioPharma, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 345.0 | 318.2 | 294.3 |
| Cost of Goods Sold | 0.0 | 0.0 | -- |
| Gross Profit | 345.0 | 318.2 | 294.3 |
| Gross Profit Margin | 100% | 100% | -- |
| SG&A Expense | 133.9 | 21.1 | 51.5 |
| Depreciation & Amortization | 0.3 | 1.0 | 22.5 |
| Operating Income | 211.1 | 297.1 | 242.7 |
| Operating Margin | 61.2% | 93.4% | 82.5% |
| Nonoperating Income | (17.6) | 1.5 | 0.7 |
| Nonoperating Expenses | (43.1) | (18.4) | -- |
| Income Before Taxes | 150.4 | 280.3 | 243.4 |
| Income Taxes | 58.5 | 90.6 | 5.0 |
| Net Income After Taxes | 91.9 | 189.7 | 238.4 |
| Continuing Operations | 91.9 | 189.7 | 238.4 |
| Discontinued Operations | 0.0 | 0.0 | (170.0) |
| Total Operations | 91.9 | 189.7 | 68.4 |
| Total Net Income | 91.9 | 189.7 | 68.4 |
| Net Profit Margin | 26.6% | 59.6% | 23.2% |
| Diluted EPS from Total Net Income | 0.54 | 1.07 | 0.47 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
PDL BioPharma, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 211.6 | 303.2 | 129.3 |
| Net Receivables | 0.5 | 1.1 | 13.5 |
| Inventories | -- | -- | -- |
| Other Current Assets | 72.6 | 11.6 | 37.9 |
| Total Current Assets | 284.7 | 315.8 | 180.7 |
| Net Fixed Assets | 0.1 | 0.2 | 1.1 |
| Other Noncurrent Assets | 31.9 | 22.4 | 9.3 |
| Total Assets | 316.7 | 338.4 | 191.1 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | 2.5 | 0.4 | 1.7 |
| Short-Term Debt | 119.2 | 277.9 | -- |
| Other Current Liabilities | 72.2 | 15.3 | 29.8 |
| Total Current Liabilities | 194.0 | 293.5 | 31.5 |
| Long-Term Debt | 395.5 | 450.1 | 500.0 |
| Other Noncurrent Liabilities | 51.4 | 10.7 | 12.2 |
| Total Liabilities | 640.8 | 754.4 | 543.7 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | -- |
| Common Stock Equity | (324.2) | (416.0) | (352.6) |
| Total Equity | (324.2) | (416.0) | (352.6) |
| Shares Outstanding (thou.) | 139,640.0 | 119,523.0 | 119,506.8 |
All amounts in millions of US Dollars except per share amounts.
PDL BioPharma, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 184 | 187 | 80 |
| Net Investing Cash Flow | (36.9) | 18.4 | 587.0 |
| Net Financing Cash Flow | (239.1) | (31.2) | (878.5) |
| Net Change in Cash | (91.7) | 174.2 | (211.4) |
| Depreciation & Amortization | 0.3 | 1.0 | 22.5 |
| Capital Expenditures | (0.0) | (3.3) | |
| Cash Dividends Paid | (130.0) | (319.0) | (912.6) |
All amounts in millions of US Dollars except per share amounts.